Showing results (5241-5250 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|September 14, 2020
Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal CarcinomaMaïmouna Mané, Sofian Benkhaled, Tatiana Dragan, et al.
The Oncologist|September 14, 2020
Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal CancerYaqi Li, Qianlan Yao, Long Zhang, et al.
The Oncologist|March 11, 2020
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid TumorsDominik Karres, Sahra Ali, Paula B van Hennik, et al.
The Oncologist|March 13, 2020
Computed Tomography-Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal CancerStéphanie M L M Looijaard, Carel G M Meskers, Monique S Slee-Valentijn, et al.
The Oncologist|March 13, 2020
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective StudyHironori Fujii, Nobuhisa Matsuhashi, Mika Kitahora, et al.
The Oncologist|March 13, 2020
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung CancerMari Aso, Yukihiro Toi, Jun Sugisaka, et al.
The Oncologist|March 13, 2020
Premature Termination of a Randomized Controlled Trial on Image-Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord CompressionMorten Hiul Suppli, Per Munck Af Rosenschold, Benny Dahl, et al.
The Oncologist|March 13, 2020
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA TrialSara A Hurvitz, Anthony Gonçalves, Hope S Rugo, et al.
The Oncologist|March 13, 2020
The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon CancerWeixing Dai, Shaobo Mo, Wenqiang Xiang, et al.
The Oncologist|March 14, 2020
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like PhenomenonShaheen Khan, Mitchell S von Itzstein, Rong Lu, et al.
Pageof 571